Announced Tue, 7 Jul · 18:29 IST
Quarterly dematerialisation compliance certificate filed with exchanges
Compliance View source PDF
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.3%1-day move
₹388.95
prior close
₹385.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+0.6+0.6—+2.3+2.2+1.7+4.3+8.6+7.6————
Up moveDown movePending
AI summary
Aarti Drugs submitted a quarterly compliance certificate under SEBI Regulation 74(5) to BSE and NSE for the quarter ended June 30, 2026. The certificate from its Registrar and Transfer Agent, MUFG Intime India Private Limited, confirms that securities received for dematerialisation were properly processed, listed on stock exchanges, and cancelled after verification, with depository names updated in the member register within required timelines. This is a routine regulatory filing.
Likely market impact
Routine quarterly compliance filing. No material impact on shareholders or stock price.